Literature DB >> 12124234

Involvement of Na(+)/Ca(2+) exchanger in endothelial NO production and endothelium-dependent relaxation.

Jean-Christophe Schneider1, Driss El Kebir, Christiane Chéreau, Jean-Christophe Mercier, Josette Dall'Ava-Santucci, A Tuan Dinh-Xuan.   

Abstract

Endothelial nitric oxide (NO) synthase (eNOS) is controlled by Ca(2+)/calmodulin and caveolin-1 in caveolae. It has been recently suggested that Na(+)/Ca(2+) exchanger (NCX), also expressed in endothelial caveolae, is involved in eNOS activation. To investigate the role played by NCX in NO synthesis, we assessed the effects of Na(+) loading (induced by monensin) on rat aortic rings and cultured porcine aortic endothelial cells. Effect of monensin was evaluated by endothelium-dependent relaxation of rat aortic rings in response to acetylcholine and by real-time measurement of NO release from cultured endothelial cells stimulated by A-23187 and bradykinin. Na(+) loading shifted the acetylcholine concentration-response curve to the left. These effects were prevented by pretreatment with the NCX inhibitors benzamil and KB-R7943. Monensin potentiated Ca(2+)-dependent NO release in cultured cells, whereas benzamil and KB-R7943 totally blocked Na(+) loading-induced NO release. These findings confirm the key role of NCX in reverse mode on Ca(2+)-dependent NO production and endothelium-dependent relaxation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12124234     DOI: 10.1152/ajpheart.00789.2001

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  12 in total

1.  The sodium-calcium exchanger is a mechanosensitive transporter.

Authors:  John P Reeves; Maha Abdellatif; Madalina Condrescu
Journal:  J Physiol       Date:  2008-01-31       Impact factor: 5.182

2.  Reverse-mode Na+/Ca2+ exchange is an important mediator of venous contraction.

Authors:  Nathan R Tykocki; William F Jackson; Stephanie W Watts
Journal:  Pharmacol Res       Date:  2012-09-10       Impact factor: 7.658

3.  Acute effects of glucose and insulin on vascular endothelium.

Authors:  D Taubert; A Rosenkranz; R Berkels; R Roesen; E Schömig
Journal:  Diabetologia       Date:  2004-12-15       Impact factor: 10.122

4.  Electrophysiological characterization of store-operated and agonist-induced Ca2+ entry pathways in endothelial cells.

Authors:  Nathalie C Girardin; Fabrice Antigny; Maud Frieden
Journal:  Pflugers Arch       Date:  2010-04-27       Impact factor: 3.657

5.  Acetaminophen treatment evokes anticontractile effects in rat aorta by blocking L-type calcium channels.

Authors:  Mikaelle C Correia; Eder S A Santos; Bruno J Neves; Matheus L Rocha
Journal:  Pharmacol Rep       Date:  2022-04-19       Impact factor: 3.024

6.  Sodium-calcium exchanger contributes to membrane hyperpolarization of intact endothelial cells from rat aorta during acetylcholine stimulation.

Authors:  Alexander Bondarenko
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

7.  Endothelial nitric oxide attenuates Na+/Ca2+ exchanger-mediated vasoconstriction in rat aorta.

Authors:  J Zhao; H Majewski
Journal:  Br J Pharmacol       Date:  2008-05-12       Impact factor: 8.739

8.  Increase in endothelial cell Ca(2+) in response to mouse cremaster muscle contraction.

Authors:  Tasmia Duza; Ingrid H Sarelius
Journal:  J Physiol       Date:  2003-12-23       Impact factor: 5.182

9.  NO-induced vasodilation correlates directly with BP in smooth muscle-Na/Ca exchanger-1-engineered mice: elevated BP does not attenuate endothelial function.

Authors:  Youhua Wang; Jin Zhang; W Gil Wier; Ling Chen; Mordecai P Blaustein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-30       Impact factor: 4.733

10.  N-Arachidonoyl glycine suppresses Na⁺/Ca²⁺ exchanger-mediated Ca²⁺ entry into endothelial cells and activates BK(Ca) channels independently of GPCRs.

Authors:  Alexander I Bondarenko; Konstantin Drachuk; Olga Panasiuk; Vadim Sagach; Andras T Deak; Roland Malli; Wolfgang F Graier
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.